In addition, determining the role of TIM-3–Gal-9 interaction versus TIM-3 inhibition on TIL, M2, MDSC, and tumor cell metabolic reprogramming in order to define the crosstalk between metabolic reprogramming of immune cells and cancer cells in this malignancy is highly recommended. This evidence concerns the gene HAVCR2 and cancer.